Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies
Authors
Keywords
-
Journal
Hormones & Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-17
DOI
10.1007/s12672-020-00385-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib
- (2020) Matthias Kroiss et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
- (2019) Chiara Fiorentini et al. Journal of Oncology
- Metastatic Adrenocortical Carcinoma: a Single Institutional Experience
- (2019) Dwight H. Owen et al. Hormones & Cancer
- PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
- (2019) Emilien Billon et al. OncoImmunology
- Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
- (2019) Mouhammed Amir Habra et al. Journal for ImmunoTherapy of Cancer
- 901OEV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma
- (2019) C J Hoimes et al. ANNALS OF ONCOLOGY
- Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors
- (2019) Salvatore Grisanti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- PD-1 Blockade in Advanced Adrenocortical Carcinoma
- (2019) Nitya Raj et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity and safety of temozolomide in advanced adrenocortical carcinoma patients
- (2019) Deborah Cosentini et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
- (2018) Elaine Silveira et al. Cancer Cell International
- Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma
- (2018) Felix Megerle et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
- (2018) Martin Fassnacht et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry
- (2018) Matthias Kroiss et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Advanced Adrenocortical Carcinoma – What to do when First-Line Therapy Fails?
- (2018) Felix Megerle et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden
- (2018) Jose Mauricio Mota et al. MEDICINE
- Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
- (2018) Christophe Le Tourneau et al. Journal for ImmunoTherapy of Cancer
- Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
- (2017) Judith E K Henning et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
- (2016) Siyuan Zheng et al. CANCER CELL
- Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene
- (2016) S. G. Creemers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide
- (2016) Matthias Kroiss et al. Hormones & Cancer
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
- (2015) Martin Fassnacht et al. LANCET ONCOLOGY
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition
- (2015) B Madan et al. ONCOGENE
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
- (2015) Phuong N. Le et al. PHARMACOLOGY & THERAPEUTICS
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
- (2014) Ciara O'Sullivan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells
- (2014) B. Mariniello et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Integrated genomic characterization of adrenocortical carcinoma
- (2014) Guillaume Assié et al. NATURE GENETICS
- The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial
- (2014) Antonio M. Lerario et al. Hormones & Cancer
- Adrenocortical Carcinoma Is a Lynch Syndrome–Associated Cancer
- (2013) Victoria M. Raymond et al. JOURNAL OF CLINICAL ONCOLOGY
- ACAT-selective and Nonselective DGAT1 Inhibition
- (2013) Jan Eike Floettmann et al. TOXICOLOGIC PATHOLOGY
- Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) A. Berruti et al. ANNALS OF ONCOLOGY
- Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
- (2012) Matthias Kroiss et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination Chemotherapy in Advanced Adrenocortical Carcinoma
- (2012) Martin Fassnacht et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
- (2011) Matthias Kroiss et al. CLINICAL ENDOCRINOLOGY
- Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma
- (2011) Irina Dobrosotskaya et al. Endocrine Practice
- Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma
- (2011) Alfredo Berruti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- [131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma
- (2011) Stefanie Hahner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adrenocortical carcinoma: a clinician's update
- (2011) Martin Fassnacht et al. Nature Reviews Endocrinology
- -Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma
- (2010) S. Gaujoux et al. CLINICAL CANCER RESEARCH
- Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study
- (2010) Paola Sperone et al. ENDOCRINE-RELATED CANCER
- Adrenocortical development and cancer: focus on SF-1
- (2010) Enzo Lalli JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Transcatheter Arterial Chemoembolization for Liver Metastases in Patients with Adrenocortical Carcinoma
- (2010) Julien Cazejust et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
- (2010) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient
- (2009) P. Boudou-Rouquette et al. ANNALS OF ONCOLOGY
- Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
- (2009) Paul Haluska et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
- (2009) Sebastian Wortmann et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists
- (2009) Mabrouka Doghman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Advanced Adrenocortical Carcinoma with Erlotinib plus Gemcitabine
- (2008) Marcus Quinkler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now